ADIAL PHARMACEUTICALS INC's ticker is ADIL and the CUSIP is 00688A106. A total of 20 filers reported holding ADIAL PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $8 | -33.3% | 36,461 | 0.0% | 0.00% | – |
| Q1 2023 | $12 | +71.4% | 36,461 | 0.0% | 0.00% | – |
| Q4 2022 | $7 | -99.9% | 36,461 | 0.0% | 0.00% | – |
| Q3 2022 | $12,000 | -75.0% | 36,461 | 0.0% | 0.00% | – |
| Q2 2022 | $48,000 | -34.2% | 36,461 | 0.0% | 0.00% | – |
| Q1 2022 | $73,000 | -25.5% | 36,461 | 0.0% | 0.00% | – |
| Q4 2021 | $98,000 | -37.2% | 36,461 | 0.0% | 0.00% | – |
| Q3 2021 | $156,000 | +110.8% | 36,461 | +25.5% | 0.00% | – |
| Q2 2021 | $74,000 | +39.6% | 29,050 | +31.7% | 0.00% | – |
| Q1 2021 | $53,000 | +194.4% | 22,050 | +107.3% | 0.00% | – |
| Q4 2020 | $18,000 | -21.7% | 10,635 | 0.0% | 0.00% | – |
| Q3 2020 | $23,000 | +64.3% | 10,635 | 0.0% | 0.00% | – |
| Q2 2020 | $14,000 | +7.7% | 10,635 | 0.0% | 0.00% | – |
| Q1 2020 | $13,000 | -48.0% | 10,635 | 0.0% | 0.00% | – |
| Q4 2019 | $25,000 | +56.2% | 10,635 | 0.0% | 0.00% | – |
| Q3 2019 | $16,000 | – | 10,635 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VANGUARD GROUP INC | 38,982 | $200,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 802 | $5,000 | 0.00% |
| UBS Group AG | 2,723 | $14,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 11,775 | $60,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 250 | $1,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 27,162 | $138,000 | 0.00% |
| MORGAN STANLEY | 545 | $3,000 | 0.00% |
| BlackRock Inc. | 205,684 | $1,053,000 | 0.00% |